Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Eleonora Scarlata
Affiliation
Research Institute of the McGill University Health Center (RI-MUHC)
ORCID
Career Start Year
1999
Papers
38
H Index
13
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37037938
A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients.
Br J Cancer
2023
37126232
Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.
J Urol
2023
37073437
Cell-by-cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression.
J Pathol Clin Res
2023
35204109
Peroxiredoxin 6 Peroxidase and Ca<sup>2+</sup>-Independent Phospholipase A<sub>2</sub> Activities Are Essential to Support Male-Mouse Fertility.
Antioxidants (Basel)
2022
35411033
Fatty acid oxidation enzyme ο3, ο2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients.
Oncogene
2022
37021966
OXIDATIVE STRESS AND REPRODUCTIVE FUNCTION: The protection of mammalian spermatozoa against oxidative stress.
Reproduction
2022
32668798
A Novel Combination of γ-Tocopherol-Rich Mixture of Tocopherols and Ascorbic Acid Restores Fertility in Cases of Tyrosine Nitration-Associated Male Infertility in Mice.
Antioxidants (Basel)
2020
31891662
Antioxidant Enzymes and Male Fertility: Lessons from Knockout Models.
Antioxid Redox Signal
2020
32093059
Long-Term Adverse Effects of Oxidative Stress on Rat Epididymis and Spermatozoa.
Antioxidants (Basel)
2020
32763409
Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification-Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples.
J Mol Diagn
2020
31633066
Snap29 mutant mice recapitulate neurological and ophthalmological abnormalities associated with 22q11 and CEDNIK syndrome.
Commun Biol
2019
30140035
The combination of PTEN deletion and 16p13.3 gain in prostate cancer provides additional prognostic information in patients treated with radical prostatectomy.
Mod Pathol
2019
30113732
Optimization of the 2014 Gleason grade grouping in a Canadian cohort of patients with localized prostate cancer.
BJU Int
2019
30136199
The relationship between body-mass index, physical activity, and pathologic and clinical outcomes after radical prostatectomy for prostate cancer.
World J Urol
2019
31433512
A three-gene DNA methylation biomarker accurately classifies early stage prostate cancer.
Prostate
2019
31340802
Improving ultrasound-based prostate volume estimation.
BMC Urol
2019
28993510
Genomic Gain of 16p13.3 in Prostate Cancer Predicts Poor Clinical Outcome after Surgical Intervention.
Mol Cancer Res
2018
28724614
Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer.
Genes Dev
2017
28152543
Asporin is a stromally expressed marker associated with prostate cancer progression.
Br J Cancer
2017
29021631
Deficiency of peroxiredoxin 6 or inhibition of its phospholipase A<sub>2</sub> activity impair the in vitro sperm fertilizing competence in mice.
Sci Rep
2017
25046623
A combination of hemostatic agents may safely replace deep medullary suture during laparoscopic partial nephrectomy in a pig model.
J Urol
2015
26714499
The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases.
EJNMMI Res
2015
25578541
Electrochemical red-ox therapy of prostate cancer in nude mice.
Bioelectrochemistry
2015
24406017
The prognostic role of ERG immunopositivity in prostatic acinar adenocarcinoma: a study including 454 cases and review of the literature.
Hum Pathol
2014
25152453
Biopsy characteristics in men with a preoperative diagnosis of prostatic adenocarcinoma with high Gleason score (8-10) predict pathologic outcome in radical prostatectomy.
Hum Pathol
2014
23680311
Endoscopic vascular targeted photodynamic therapy with the photosensitizer WST11 for benign prostatic hyperplasia in the preclinical dog model.
J Urol
2013
24194978
Strategies for biochemical and pathologic quality assurance in a large multi-institutional biorepository; The experience of the PROCURE Quebec Prostate Cancer Biobank.
Biopreserv Biobank
2013
23906537
The Fer tyrosine kinase acts as a downstream interleukin-6 effector of androgen receptor activation in prostate cancer.
Mol Cell Endocrinol
2013
21882212
Refining the orthotopic dog prostate cancer (DPC)-1 model to better bridge the gap between rodents and men.
Prostate
2012
23401739
The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease Progression.
Transl Oncol
2012
22200970
Banking of fresh-frozen prostate tissue using the alternate mirror image protocol: methods, validation, and impact on the pathological prognostic parameters in radical prostatectomy.
Cell Tissue Bank
2012
21600602
Preclinical study of the novel vascular occluding agent, WST11, for photodynamic therapy of the canine prostate.
J Urol
2011
19147545
The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth.
Mol Cancer Res
2009
20061787
Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder cancer.
Cancer Biol Ther
2009
19399787
Botulinum toxin type A inhibits the growth of LNCaP human prostate cancer cells in vitro and in vivo.
Prostate
2009
16857789
Isolation of human prostatic epithelial plasma membranes for proteomics using mirror image tissue banking of radical prostatectomy specimens.
Clin Cancer Res
2006
10481620
Filamentous intranuclear inclusion bodies in psittacine birds. A structural and ultrastructural study.
Zentralbl Veterinarmed B
1999
10204226
Rupture of the gracilis muscle in Iberian pigs at slaughter.
Vet Rec
1999
1 - 38 of 38
Column Actions
Search
Recommended Authors
Yaser Gamallat
Cumming School of Medicine, University of Calgary
Career Start Year
2016
Number of shared co-authors
1
Alia Albawardi
College of Medicine and Health Sciences, United Arab Emirates University
Career Start Year
2010
Number of shared co-authors
1
Young-Won Kim
Baylor College of Medicine
Career Start Year
2009
Number of shared co-authors
1
Anne Haegert
University of British Columbia
Career Start Year
2008
Number of shared co-authors
4
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Career Start Year
2008
Number of shared co-authors
5
Brian W Simons
Center for Comparative Medicine, Baylor College of Medicine
Career Start Year
2008
Number of shared co-authors
1
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year
2005
Number of shared co-authors
8
Amirali Salmasi
University of California San Diego
Career Start Year
2005
Number of shared co-authors
1
Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year
2004
Number of shared co-authors
2
Ran Lee
Korea National College of Agriculture and Fisheries, Sangji University
Career Start Year
2004
Number of shared co-authors
0
Robert H Bell
University of British Columbia
Career Start Year
2004
Number of shared co-authors
4
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year
2003
Number of shared co-authors
6
Leena Latonen
Foundation for the Finnish Cancer Institute
Career Start Year
1999
Number of shared co-authors
0
H??l??ne Hovington
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year
1999
Number of shared co-authors
12
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year
1997
Number of shared co-authors
5
David Clouston
Career Start Year
1995
Number of shared co-authors
2
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year
1994
Number of shared co-authors
4
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year
1991
Number of shared co-authors
3
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year
1989
Number of shared co-authors
4
Bernd Wullich
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year
1989
Number of shared co-authors
0
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year
1988
Number of shared co-authors
0
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year
1988
Number of shared co-authors
4
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year
1987
Number of shared co-authors
6
Freddie C Hamdy
University of Oxford
Career Start Year
1987
Number of shared co-authors
5
Dean A Troyer
Eastern Virginia Medical School
Career Start Year
1985
Number of shared co-authors
9
Lawrence D True
University of Washington School of Medicine
Career Start Year
1980
Number of shared co-authors
11
William B Isaacs
The Brady Urological Institute, The Johns Hopkins School of Medicine
Career Start Year
1979
Number of shared co-authors
6
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Career Start Year
1975
Number of shared co-authors
4
Theodorus H van der Kwast
University Health Network, University of Toronto
Career Start Year
1974
Number of shared co-authors
20
William E Grizzle
University of Alabama at Birmingham
Career Start Year
1974
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Simone Chevalier
McGill University Health Centre, McGill University
Co-authored papers
26
Armen Aprikian
McGill University Health Centre, McGill University
Co-authored papers
21
Fadi Brimo
McGill University Health Centre, McGill University
Co-authored papers
19
Karl-Philippe Gu??rard
McGill University and the Research Institute of the McGill University Health Centre
Co-authored papers
8
Fred Saad
University of Montreal Health Center
Co-authored papers
5
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers
4
Palak G Patel
Queen's University
Co-authored papers
4
Louis Lacombe
CHU de Quebec-Universite Laval
Co-authored papers
4
Tamara Jamaspishvili
Queen's University
Co-authored papers
4
John M S Bartlett
University of Edinburgh
Co-authored papers
4
Walead Ebrahimizadeh
Current affiliation: IMV Inc.
Co-authored papers
3
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Co-authored papers
3
David M Berman
Queen's University
Co-authored papers
3
Madeleine Moussa
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers
2
Nathan E How
Queen's University Cancer Research Institute
Co-authored papers
2
Paul C Boutros
University of California los angeles
Co-authored papers
2
Joseph L Chin
University of Western Ontario
Co-authored papers
2
Amina Zoubeidi
University of British Columbia
Co-authored papers
2
Nadia Boufaied
Research Institute of the McGill University Health Centre
Co-authored papers
2
Anna Y Lee
Ontario Institute for Cancer Research
Co-authored papers
2
Glenn Bauman
Western University and London Regional Cancer Program
Co-authored papers
2
Dan Dion
Ontario Institute for Cancer Research (OICR)
Co-authored papers
1
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers
1
Shawn M Chevalier
McGill University and the Research Institute of the McGill University Health Centre
Co-authored papers
1
Guillaume Bourque
Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University
Co-authored papers
1
Suzanne Boursalie
University
Co-authored papers
1
Khalil Hetou
Co-authored papers
1
David M Berman
Queen's University
Co-authored papers
1
Jeremy A Squire
University of Sao Paulo
Co-authored papers
1
Martin E Gleave
University of British Columbia
Co-authored papers
1
1 - 30